5Edmond MB,Wallace SE,McClish DK.Nosocomial bloodstream infections in United States hospital:a three year analysis[J].Clin Infect Dis,1999,29(2):239-244.
6Edmond MB,Wallace SE,McClish DK.Nosocomial bloodstream infections in United States hospital:a three year analysis[J].Clin Infect Dis,1999,29(2): 239-244.
7Bodey GP,Mardani M,Hanna HA,et al.The epidemiology of Candida glabrata and Calldida albicans fungemia in immunocompromised patients with cancer[J].Am J Med,2002,112(5):380-385.
8Metcalf SC,Dockrell DH.Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts[J].J Infect,2007,55(4):287-299.
9Patterson TF.Advances and challenges in management of invasive mycoses[J].Lancet,2005,366(9490):1013-1025.
10Patterson TF.Advances and challenges in management of invasive mycoses[J].Lancet,2005,366(9490):1013-1025.
